Grants per year
Personal profile
Certifications and Licenses
| Medical Oncology | |
| Hematology | |
| Internal Medicine |
Training Experience
| 2004 | Residency, University of Chicago Hospitals |
| 2007 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
MD, Medicine, University of Pittsburgh
… → 2001
Research interests keywords
- Acute Leukemias
- Anemia
- Aplastic Anemia
- Chronic Leukemias
- Leukemia
- Myelodysplastic Syndrome
- Myeloproliferative Diseases
- Targeted Therapies
Fingerprint
Dive into the research topics where Jessica K Altman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #2215-CL-0203: A Phase 1/2, Multicenter, Open-Label, Randomized Dose Ranging and Expansion Study of the Combination of Gilteritinib, Venetoclax and Azacitidine in Patients with Newly Diagnosed FLT3 Mutated Acute Myeloid Leukemia (AML) not Eligible fo
Parexel, Astellas Pharma Global Development, Inc.
3/13/23 → 3/13/26
Project: Research project
-
Liquid Biopsy to Measure Novel Biomarkers of ImmunoMetabolic Cancer Risk (IMCR)
Thaxton, C. S., Abaza, Y., Altman, J. K., Behdad, A. & Griffith, J. W.
V Foundation for Cancer Research
8/1/22 → 8/1/25
Project: Research project
-
Prot #APTO-CG-806-03: A Phase 1a/b Trial of CG-806 in Patients with Relapsed/Refractory Acute Myeloid Leukemia
1/27/21 → 1/27/24
Project: Research project
-
Acute Myeloid Leukemia, Version 3.2023
Pollyea, D. A., Altman, J. K., Assi, R., Bixby, D., Fathi, A. T., Foran, J. M., Gojo, I., Hall, A. C., Jonas, B. A., Kishtagari, A., Lancet, J., Maness, L., Mangan, J., Mannis, G., Marcucci, G., Mims, A., Moriarty, K., Ali, M. M., Neff, J., Nejati, R., & 17 others, May 2023, In: JNCCN Journal of the National Comprehensive Cancer Network. 21, 5, p. 503-513 11 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study
Garcia-Manero, G., Goldberg, A. D., Winer, E. S., Altman, J. K., Fathi, A. T., Odenike, O., Roboz, G. J., Sweet, K., Miller, C., Wennborg, A., Hickman, D. K., Kanagal-Shamanna, R., Kantarjian, H., Lancet, J., Komrokji, R., Attar, E. C. & Sallman, D. A., Apr 2023, In: The Lancet Haematology. 10, 4, p. e272-e283Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371
Chen, H., Bai, Y., Kobayashi, M., Xiao, S., Cai, W., Barajas, S., Chen, S., Miao, J., Meke, F. N., Vemula, S., Ropa, J. P., Croop, J. M., Boswell, H. S., Wan, J., Jia, Y., Liu, H., Li, L. S., Altman, J. K., Eklund, E. A., Ji, P., & 6 others, Jan 19 2023, In: Blood. 141, 3, p. 244-259 16 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study
DiNardo, C. D., De Botton, S., Pollyea, D. A., Stone, R. M., Altman, J. K., Fathi, A. T., Limsakun, T., Liang, M., Choe, S., Hossain, M., Tron, A. E., Meng, Q., Kapsalis, S. M., Pandya, S. S. & Stein, E. M., Sep 2023, In: American Journal of Hematology. 98, 9, p. E233-E236Research output: Contribution to journal › Letter › peer-review
Open Access -
TP53-altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity
Shallis, R. M., Daver, N. G., Altman, J. K., Hasserjian, R. P., Kantarjian, H. M., Platzbecker, U., Santini, V., Wei, A. H., Sallman, D. A. & Zeidan, A. M., Jan 15 2023, In: cancer. 129, 2, p. 175-180 6 p.Research output: Contribution to journal › Article › peer-review
5 Scopus citations